Lehr Martin A. 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-12 5:20 pm Purchase | 2024-12-31 | 13G | Context Therapeutics Inc. CNTX | Lehr Martin A. | 1,595,742 2.100% | 143,276![]() (+9.86%) | Filing |
2024-02-07 4:24 pm Purchase | 2023-12-31 | 13G | Context Therapeutics Inc. CNTX | Lehr Martin A. | 1,452,466 8.800% | 1,452,466![]() (New Position) | Filing |